Close

Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

×

Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Zimmer Biomet: FCPA probe remains ongoing

Jaclyn Jaeger | March 28, 2016

Medical device maker Zimmer Biomet Holdings (formerly Biomet) said last week in a securities filing that it’s still under investigation by the Department of Justice and Securities and Exchange Commission for possible violations of the Foreign Corrupt Practices Act regarding its operations in Brazil and Mexico.

As Compliance Week previously reported, Biomet entered into a three-year deferred prosecution agreement in 2012 with the Justice Department, and a parallel consent agreement with the SEC, for possible violations of the FCPA. Then, in October 2013, Biomet...

Buy this article for $49, or subscribe to Compliance Week for a month at $149 and get unlimited article access for 30 days.